Operational Burden Signal

HLX43

HLX43 is flagged as operational burden signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Back to report Open sponsor view

Program overview

Context

Indication: Hormone Receptor Positive HER-2 Negative Breast Cancer

Mechanism: Unknown

Modality: Unknown

Sponsor: Shanghai Henlius Biotech

Scores

Risk-signal summary

Registry: 0/5

Timeline: 0/5

Recruitment burden: 4/5

Results availability: 0/5

Program risk: 2/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT07459738 | https://clinicaltrials.gov/study/NCT07459751

Linked trials

Trial-level signal details

Trial	Status	Timeline	Results	Burden
NCT07459738	Low Signal (NOT_YET_RECRUITING)	None	Low Signal	strict_eligibility_signal
NCT07459751	Low Signal (RECRUITING)	None	Low Signal	large_enrollment_target_signal \| few_sites_large_trial_signal \| rare_population_signal \| strict_eligibility_signal